|Bid||0.00 x 1200|
|Ask||0.00 x 1800|
|Day's Range||17.60 - 18.33|
|52 Week Range||15.83 - 31.18|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||21.22|
|Earnings Date||Feb 07, 2022 - Feb 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.50|
Subscribe to Yahoo Finance Plus to view Fair Value for CORTLearn more
The mean of analysts' price targets for Corcept (CORT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CORT vs. ZTS: Which Stock Is the Better Value Option?
A look at the shareholders of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) can tell us which group is most...